GFAP and colitis: The number of GFAP-ir glia per ganglion showed an increase of 34.5% in the Colitis group (20.6 ± 0.1) when compared to the Sham group (15.3 ± 0.1; p < 0.0001) and a reduction of 24.20% in the Butyrate group (15.7 ± 0.2; p < 0.0001), compared to the Colitis group (Figure 6D).